{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:03:04Z","timestamp":1767945784715,"version":"3.49.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to identify factors influencing recurrence after laparoscopic radical cystectomy for bladder cancer (BC) based on serum levels of miR-18a and miR-122, and to develop and validate a nomogram prediction model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The relevant information of BC patients who received laparoscopic radical cystectomy procedure in our hospital from January 2021 to October 2022 was collected retrospectively. The patients were divided into a training set and a validation set at a ratio of 7:3 by the complete randomization method. Independent predictive variables included in the Nomogram model were determined and modeled through univariate analysis and multivariate Logistic regression analysis. The receiver operating characteristic curve (ROC) and calibration curves were used to evaluate the predictive efficacy of the model, and decision curve analysis (DCA) was used to evaluate its clinical application value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 280 research subjects were included. Recurrence occurred in 46 (23.47%) of the 196 patients in the training set and 21 (25.00%) of the 84 patients in the validation set. The results of the multivariate logistic regression analysis showed that preoperative serum miR-18a levels, preoperative serum miR-122 levels, postoperative serum carcinoembryonic antigen levels, postoperative serum carbohydrate antigen 19\u20139 levels, and postoperative antibiotic use duration were significantly associated with recurrence after laparoscopic radical cystectomy for BC. The model was well calibrated and fitted in the training and validation sets. The ROC curve showed that the AUC of the nomogram model to predict postoperative recurrence were 0.796(95% CI: 0.688-0.904) and 0.762(95% CI: 0. 578-0.946), respectively. DCA indicated that the model had clinical application value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The Nomogram model for recurrence after laparoscopic radical cystectomy procedure for BC has good prediction ability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1579873","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:42:02Z","timestamp":1767940922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling and validation of serum miR-18a and miR-122 levels as predictors of recurrence after laparoscopic radical cystectomy procedure for bladder cancer based on nomogram model"],"prefix":"10.3389","volume":"15","author":[{"given":"Peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"104551","DOI":"10.1016\/j.isci.2022.104551","article-title":"The origin of bladder cancer from mucosal field effects","volume":"25","author":"Bondaruk","year":"2022","journal-title":"iScience"},{"key":"B2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41585-022-00611-3","article-title":"Bladder cancer, inflammageing and microbiomes","volume":"19","author":"Martin","year":"2022","journal-title":"Nat Rev Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12885-024-11816-7","article-title":"Feasibility and safety of laparoscopic radical cystectomy for male octogenarians with muscle-invasive bladder cancer","volume":"24","author":"Pan","year":"2024","journal-title":"BMC Can"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14858","article-title":"Serum microRNA as liquid biopsy biomarker for the prediction of oncological outcomes in patients with bladder cancer","volume":"29","author":"Urabe","year":"2022","journal-title":"Int J Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2066755","article-title":"Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting Sprouty 4","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3390\/cells11101672","article-title":"miR-18a mediates immune evasion in ER-positive breast cancer through wnt signaling","volume":"11","author":"Nair","year":"2022","journal-title":"Cells"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2224512","DOI":"10.1080\/15384047.2023.2224512","article-title":"MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K\/AKT pathway","volume":"24","author":"Liu","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-2269","article-title":"Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis","volume":"82","author":"Sendi","year":"2022","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvad133","article-title":"Diagnostic miRNA signatures in paired tumor, plasma, and urine specimens from renal cell carcinoma patients","volume":"70","author":"Bustos","year":"2024","journal-title":"Clin Chem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2500104","DOI":"10.1080\/15384047.2025.2500104","article-title":"Exosomal miR-122-5p for regulation of secretory functions of fibroblasts and promotion of breast cancer metastasis by targeting MKP-2: an experimental study","author":"Lv","year":"2025","journal-title":"Cancer Biol Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1001381","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PloS Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6787","article-title":"Sample size considerations for the external validation of a multivariable prognostic model: a resampling study","volume":"35","author":"Collins","year":"2016","journal-title":"Stat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-022-01056-4","article-title":"Combined exome and transcriptome sequencing of non-muscle-invasive bladder cancer: associations between genomic changes, expression subtypes, and clinical outcomes","volume":"14","author":"Goel","year":"2022","journal-title":"Genome Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.32074\/1591-951X-838","article-title":"News in the classification of WHO 2022 bladder tumors","volume":"115","author":"Raspollini","year":"2022","journal-title":"Pathologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5114\/wiitm.2022.118162","article-title":"Long-term functional outcomes of vesicourethral anastomosis with bladder neck preservation and distal urethral length preservation after videol aparoscopic radical prostatectomy","volume":"17","author":"Wiatr","year":"2022","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"key":"B16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s00345-024-05185-w","article-title":"Differential effect of surgical technique on intravesical recurrence after radical nephroureterectomy in patients with upper tract urothelial c ancer: a systematic review and Meta-analysis","volume":"42","author":"Tsuboi","year":"2024","journal-title":"World J Urol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-023-00648-0","article-title":"Primary signet-ring cell carcinoma of the bladder treated with laparoscopic radical cystectomy: a case report","volume":"13","author":"Mukae","year":"2024","journal-title":"Int Cancer Conf J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1011926","DOI":"10.1371\/journal.ppat.1011926","article-title":"Exosomes derived from bladder epithelial cells infected with uropathogenic Escherichia coli increase the severity of urinary tract infections (UTIs) by impairing macrophage function","volume":"20","author":"Wang","year":"2024","journal-title":"PloS Pathog"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.04.023","article-title":"CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer[J","volume":"470","author":"Wang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1479988","article-title":"Beta-human chorionic gonadotropin, carbohydrate antigen 19-9, cancer antigen 125, and carcinoembryonic antigen as prognostic and predictive biological markers in bladder cancer","volume":"14","author":"Yuk","year":"2024","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s12094-023-03339-7","article-title":"Correlation between carcinoembryonic antigen (CEA) expression and EGFR mutations in non-small-cell lung cancer: a meta-analysis","volume":"26","author":"Gan","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"101951","DOI":"10.1016\/j.mcp.2024.101951","article-title":"Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments","volume":"73","author":"Capuozzo","year":"2024","journal-title":"Mol Cell Probes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858813","article-title":"High carbohydrate antigen 19\u20139 levels indicate poor prognosis of upper tract urothelial carcinoma","volume":"12","author":"Jeong","year":"2022","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0455","article-title":"Disruption of the gut microbiota confers cisplatin resistance in epithelial ovarian cancer","volume":"82","author":"Chambers","year":"2022","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1579873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:42:02Z","timestamp":1767940922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1579873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":24,"alternative-id":["10.3389\/fonc.2025.1579873"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1579873","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1579873"}}